Why the study?
Is the 9p21 Rs1333040 polymorphism associated with coronary microvascular obstruction in STEMI patients treated by primary angioplasty?
Is the 9p21 Rs1333040 polymorphism associated with coronary microvascular obstruction in STEMI patients treated by primary angioplasty?
Answers are grounded in this paper and cite their sources.
The T/T genotype of the 9p21 Rs1333040 polymorphism is associated with a higher incidence of microvascular obstruction and poorer collateral circulation in STEMI patients undergoing primary PCI.
BACKGROUND: Microvascular obstruction (MVO) after primary percutaneous coronary intervention (pPCI) leads to higher incidence of both early and late complications. A number of single nucleotide polymorphisms in 9p21 chromosome have been shown to affect angiogenesis in response to ischaemia. In particular, Rs1333040 with its three genotypic vriants C/C, T/C and T/T might influence the occurrence of MVO after pPCI. METHODS: We enrolled ST-elevation myocardial infarction (STEMI) patients undergoing pPCI. The Rs1333040 polymorphism was evaluated by polymerase chain reaction-restriction fragment length polymorphism using restriction endonucleases (Bsml). Two expert operators unaware of the patients' identity performed the angiographic analysis; collaterals were assessed applying Rentrop's classification. Angiographic MVO was defined as a post-pPCI Thrombolysis In Myocardial Infarction (TIMI)<3 or TIMI 3 with myocardial blush grade 0 or 1, whereas electrocardiographic MVO was defined as ST segment resolution <70% one hour after pPCI. CONCLUSION: Rs1333040 polymorphism genetic variants portend different MVO incidence. In particular, T/T genotype is related to angiographic and electrocardiographic MVO and to worse collaterals towards the culprit artery.
No takes yet. Share an insight, caveat, or question.
Fracassi et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: